SiTime Corporation SITM Plans 12 Billion Convertible Notes Offering to Fund Renesas Timing Business Acquisition Coastal Erosion Threatens UK Infrastructure The Slapton Line Collapse and Economic Implications Prediction Markets Spark Legal Clash Between US States and Federal Regulators Quantum Computing Stocks Surge on US Governments 2 Billion Funding Plan Analyst Report Highlights Pinterest Incs Growth Potential and Market Position Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Restrictions AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges VRTX Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick LND Q1 2026 Earnings Negative EPS Reported Amid Challenging Agricultural Season GLOO Q4 2025 Earnings Narrowing Losses and Strategic Repositioning Drive Stock Surge IPI Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions Iveda Solutions IVDA Q2 2024 Earnings Narrower Loss Beats Expectations Despite Revenue Uncertainty WEBTOON Entertainment WBTN Slides 14 as Stock Navigates Key Support Levels Lindsay Corporation LNN Holds Steady Near Resistance Technical Analysis and Outlook Resolute Holdings Management RHLD Surges 373 as Momentum Builds Globa Terra Acquisition Corporation Rights GTERR Trades Steady Near Support at 010 Instil Bio Inc TIL Holds Steady Near Key Support After Modest Uptick SpaceX and OpenAI Potential IPOs Could Eclipse Berkshire Hathaways Market Cap on Debut VICR Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment Merchants Bancorp Preferred Series C MBINN Edges Higher as Support Holds FLD Q1 2026 Earnings Steep EPS Miss Triggers DoubleDigit Stock Decline NWSA Q1 2026 Earnings EPS Beat by 1206 on Strong Operating Performance UUUU Q1 2026 Earnings NarrowerThanExpected Loss Amid Uranium Market Strength Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances IQST Q4 2025 Earnings Deep EPS Miss as Losses Widen Revenue Data Unavailable MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline SPME Q1 2026 Earnings Preferred Shares Miss EPS Estimates Stock Declines